Name & Company Information Location Interests
user-icon

Rebecca Abbott

March of Dimes

Director, Public Policy

Washington

Washington

United States

user-icon

Mr. Reza Afkhami

Surrozen

VP Corporate Development and Strategy

South San Francisco

California

United States

RBP_2011-Edit

Gautam Aggarwal

Triangle Insights Group, LLC

Partner

Durham

North Carolina

United States

Drug>Clinical, Drug>Market - Drug (on Patent), Interest Area>Biologics, Interest Area>Business Development & Finance, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Metabolic Diseases, Interest Area>Oncology, Interest Area>Value, Investor>VC/PE, Service>Consulting, Session Tracks>Business Development & Finance, Session Tracks>Genome Editing, Session Tracks>Oncology, Session Tracks>Value‚ Patient Access‚ & Reimbursement
user-icon

Samuel Agresta

Infinity Pharmaceuticals

Chief Medical Officer

Cambridge

Massachusetts

United States

user-icon

Dr. Andrew Aherrera

Cugene Inc.

Head of Business Development

Waltham

Massachusetts

United States

user-icon

Mr. Jaeyoung Ahn

Voronoi

Head of BD

Incheon

Korea, Republic of

545055-9fecb268-4303-4a8a-bf1c-dfb208ec3e81

Murray Aitken

IQVIA Institute for Human Data Science

Executive Director

New York

New York

United States

2TMTeBD

Ms. Lisa Alderson

Genome Medical

Co-founder and CEO

South San Francisco

California

United States

544193-07f79335-d052-4d7b-9d3f-764423bf635c

Dr. Wendy Alderton

Cambridge University, UK

Cancer Research UK Cambridge Centre Early Detection Programme Manager

Cambridge

Cambridge

United Kingdom

BioPro_Logo_rgb

Jim Alferman

Sekisui

Associate Director, Business Development

Maidstone

United Kingdom

Interest Area>Cell Biology, Interest Area>Diagnostics, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Session Tracks>Next Generation Biotherapeutics
user-icon

Brandon Allgood

Numerate

CTO

San Francisco

California

United States

user-icon

Cambria Alpha-Cobb

Momenta Pharmaceuticals

Patent Agent

Boston

Massachusetts

United States

395419

Dr. Michael Altorfer

Swiss Biotech Association

CEO

Zürich

Zurich

Switzerland

user-icon

David Anderson

Spark Therapeutics

CNS Research Lead

544533-bea5e4d9-8cb9-4652-b03d-3037d009edd5

Mr. Django Andrews

Sarepta Therapeutics, Inc.

Director, Sr. Patent Counsel

Cambridge

Massachusetts

United States

613704-58db9718-4867-4ece-b5e4-8eb5ce708877

Christopher Anselmo

Muscular Dystrophy Association

Market Intelligence Manager

Westbrook

Connecticut

United States

userPhoto

Fredrik Aslund

European Patent Office

Team Manager

Munich

Germany

user-icon

Anil Asnani

Labcorp

VP

Burlington

North Carolina

United States

user-icon

Dr. Hartley Atkinson

AFT Pharmaceuticals Inc.

CEO

Sydney

New South Wales

Australia

user-icon

Jessica Atkinson

Foundation Medicine, Inc

Senior Director, Corporate and Business Development

Cambridge

Massachusetts

United States

619245-58f6d4cd-a3d4-4a99-ac1b-a400a75df7eb

James E Audia

Northwestern University

Executive Director

Evanston

Illinois

United States

614788-4c1c9a1c-ee07-487c-bbef-1f8e5c0c7203

Christopher Austin

National Institutes of Health

Director, National Center for Clinical and Translational Sciences

Bethesda

Maryland

United States

542891-22880472-517b-48a0-80d1-56b84011c43e

Mr. John Babitt

Ernst & Young, LLP

Partner

New York

New York

United States

user-icon

Gerri Baer

U.S. Food and Drug Administration

Medical Officer, Neonatology Team Leader

Silver Spring

Maryland

United States

Interest Area>Central Nervous System, Interest Area>Drug Delivery, Interest Area>Medical Devices, Interest Area>Orphan & Rare Diseases, Interest Area>Preclinical/Research, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Interest Area>Therapeutics, Interest Area>Translational Research, Session Tracks>Digital Health, Session Tracks>Orphan & Rare Diseases, Session Tracks>Translational Research
David 2010

Mr. David Baker

Vallon Pharma

President & CEO

Philadelphia

Pennsylvania

United States

Academic/Non-Profit>Foundation/Patient Advocacy, Drug>Clinical, Drug>Market - Drug (on Patent), Interest Area>Brain Health, Interest Area>Business Development & Finance, Interest Area>CNS/Neurological, Session Tracks>Brain Health, Session Tracks>Business Development & Finance, Session Tracks>Digital Health, Session Tracks>Intellectual Property
user-icon

Dr. Annette Bakker

Children’s Tumor Foundation

President

New York

New York

United States

user-icon

Daniel Barber

Aquestive Therapeutics

Chief Strategy & Development Officer

user-icon

Dr. Christopher Barden

Treventis

CEO

Toronto

Ontario

Canada

AI_4980

Phil Barish

AbSci

SVP of Alliance Management

Vancouver

Washington

United States

Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Session Tracks>Business Development & Finance, Session Tracks>Genome Editing, Session Tracks>Next Generation Biotherapeutics
270x270_0020_BARKER_Tom

Mr. Thomas Barker

Foley Hoag LLP

Partner

Washington

District Of Columbia  

United States

user-icon

Abi Barrow

Cambridge Innovation Partners

Cambridge

Massachusetts

United States

user-icon

Eran Bashan

Hygieia

CEO

Ann Arbor

Michigan

United States

357536

Dr. Josep Bassaganya-Riera

Landos Biopharma

Chairman and CEO

Blacksburg

Virginia

United States

Investor>VC/PE
user-icon

Alex Bastian

Incyte Corporation

Senior Director Global Pricing & Reimbursement

Amsrerdam

Netherlands

userPhoto

Mr. Steve Bates

BioIndustry Association

CEO

London

London

United Kingdom

637243-9394184f-76ca-4e0f-88e1-401af9c66ecc

Gaurav Batra

Translational Health Science and Technology Institute

Assistant Professor, Translational Health Science and Technology Institute

Faridabad

Haryana

India

user-icon

Dr. Nina Bauer

FloDesign Sonics

VP Business Development

Wilbraham

Massachusetts

United States

roy_baynes_200x200

Roy Baynes

Merck Research Laboratories

Senior Vice President, Global Clinical Development & Chief Medical Officer

Rahway

New Jersey

United States

user-icon

Andrew Beck

Path AI, Inc.

Co-Founder and CEO

Boston

Massachusetts

United States

user-icon

Lisa Beck

Brii Biosciences

VP Business Development

Durham

North Carolina

United States

Diagnostics/Device/Digital Health>Patient Monitoring Device, Drug>Clinical, Interest Area>Biologics, Interest Area>Brain Health, Interest Area>Business Development & Finance, Interest Area>Cell Biology, Interest Area>Central Nervous System, Interest Area>Corporate Best Practices & Leadership, Interest Area>Digital Health, Interest Area>Drug Delivery, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Genetic Disorders, Interest Area>Hematology, Interest Area>Infectious Diseases & Vaccines, Interest Area>Intellectual Property, Interest Area>Nanotechnology, Interest Area>Neurological Disease, Interest Area>Orphan & Rare Diseases, Interest Area>Partnering, Interest Area>Regenerative Medicine, Interest Area>Therapeutics, Interest Area>Value, Research Tools/Support>Digital Health, Service>CRO & Analytical Labs, Service>Investment Banking Or Lending, Service>Legal, Service>Marketing/Market Research, Session Tracks>Brain Health, Session Tracks>Business Development & Finance, Session Tracks>Corporate Best Practices & Leadership, Session Tracks>Digital Health, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Genome Editing, Session Tracks>Infectious Diseases & Vaccines, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Orphan & Rare Diseases
Jake_Becraft

Jacob Becraft

Strand Therapeutics

Co-Founder

Boston

Massachusetts

United States

544197-c819bfa5-651f-4d4c-85a9-360ceed1b361

Dr. Aleksandr Bedenkov

AstraZeneca

Medical Affairs Vice-president, International Region

Luton

United Kingdom

user-icon

Dr. Jeffrey Bemis

Litron Laboratories

Director of Clinical Studies

Rochester

New York

United States

544222-513498be-13fa-49a2-9bca-8a12513b5f61

Ms. Cynthia Bens

Personalized Medicine Coalition

Senior Vice President, Public Policy

Washington

District Of Columbia  

United States

Academic/Non-Profit>Foundation/Patient Advocacy, Diagnostics/Device/Digital Health>Molecular/Cellular Diagnostics, Diagnostics/Device/Digital Health>Non Drug Delivery Device, Diagnostics/Device/Digital Health>Non-Molecular Diagnostics, Diagnostics/Device/Digital Health>Patient Monitoring Device, Drug>Clinical, Interest Area>Biologics, Interest Area>Brain Health, Interest Area>CNS/Neurological, Interest Area>Central Nervous System, Interest Area>Diagnostics, Interest Area>Digital Health, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Genetic Disorders, Interest Area>Genomics, Interest Area>Immunology, Interest Area>Medical Devices, Interest Area>Molecular Diagnostics, Interest Area>Neurological Disease, Interest Area>Non-Profit/Patient Advocacy Group, Interest Area>Oncology, Interest Area>Orphan & Rare Diseases, Interest Area>Patient Access & Reimbursement, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Pharmacogenomics, Interest Area>Regenerative Medicine, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Interest Area>Screening, Interest Area>Stem Cell Research, Interest Area>Value, Research Tools/Support>Digital Health, Research Tools/Support>Research Technology, Session Tracks>Brain Health, Session Tracks>Digital Health, Session Tracks>Genome Editing, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Oncology, Session Tracks>Orphan & Rare Diseases, Session Tracks>Personalized Medicine & Diagnostics, Session Tracks>Regulatory Innovation, Session Tracks>Value‚ Patient Access‚ & Reimbursement
user-icon

Dan Berglund

State Science & Technology Institute

President and CEO

Westerville

Ohio

United States

user-icon

Chris Bergstrom

Boston Consulting Group

Associate Director

414416

Fabian Berkemeier

IGES Institute (Germany)

Director Value and Access Strategy

user-icon

Kevin Bernier

Bayer Pharma AG

Director of Advocacy Relations

Whippany

New Jersey

United States

contact_11478

Doug Berven

Poet, LLC

V.P. of Corporate Affairs

Sioux Falls

South Dakota

United States

538788-f4c53b64-7ffc-4923-afe7-b76b9861aa24

Florence Bietrix

EATRIS

Operations Manager

Amsterdam

Netherlands